Detalles de la búsqueda
1.
Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Respir Res
; 20(1): 18, 2019 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30691468
2.
Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Respir Res
; 19(1): 224, 2018 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30458866
3.
Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in Sweden.
Value Health
; 17(7): A642-3, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202303
4.
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment Scenarios.
Value Health
; 17(7): A557-8, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27201829
Resultados
1 -
4
de 4
1
Próxima >
>>